| Literature DB >> 30131781 |
Sabrina Giaretta1, Laura Treu1,2, Veronica Vendramin1, Vinícius da Silva Duarte3, Armin Tarrah1, Stefano Campanaro4, Viviana Corich1, Alessio Giacomini1.
Abstract
Streptococcus thermophilus is a species widely used in the dairy industry for its capability to rapidly ferment lactose and lower the pH. The capability to use galactose produced from lactose hydrolysis is strain dependent and most of commercial S. thermophilus strains are galactose-negative (Gal-), although galactose-positive (Gal+) would be more technologically advantageous because this feature could provide additional metabolic products and prevent galactose accumulation in foods. In this study, a next generation sequencing transcriptome approach was used to compare for the first time a Gal+ and a Gal- strain to characterize their whole metabolism and shed light on their different properties, metabolic performance and gene regulation. Transcriptome analysis revealed that all genes of the gal operon were expressed very differently in Gal+ and in the Gal- strains. The expression of several genes involved in mixed acid fermentation, PTS sugars transporter and stress response were found enhanced in Gal+. Conversely, genes related to amino acids, proteins metabolism and CRISPR associated proteins were under-expressed. In addition, the strains showed a diverse series of predicted genes controlled by the transcriptional factor catabolite control protein A (CcpA). Overall, transcriptomic analysis suggests that the Gal+ strain underwent a metabolic remodeling to cope with the changed environmental conditions.Entities:
Keywords: CcpA; Galactose metabolism; RNA-seq; comparative transcriptome analysis; gal-lac operon; mixed acid fermentation
Year: 2018 PMID: 30131781 PMCID: PMC6090898 DOI: 10.3389/fmicb.2018.01765
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
S. thermophilus strains origin and optical density (OD600) values after 24 h of growth in M17 containing 1% galactose.
| TH1436 | 0.67 ± 0.08 | Friuli Venezia Giulia | Raw milk | Goat | Treu et al., |
| TH1435 | 0.28 ± 0.02 | Friuli Venezia Giulia | Raw milk | Goat | Treu et al., |
| TH1477 | 0.21 ± 0.03 | Veneto | Raw milk | Cow | Treu et al., |
| 1F8CT | 0.09 ± 0.01 | Veneto | Curd from raw milk | Cow | Treu et al., |
| TH982 | 0.24 ± 0.09 | Campania | Mozzarella curd | Buffalo | Treu et al., |
| TH985 | 0.28 ± 0.07 | Campania | Mozzarella whey | Buffalo | Treu et al., |
Values are means ± standard deviations from 3 independent experiments with 4 technical replicates each.
Optical density (OD600) of TH1436 (Gal+) and TH1477 (Gal−) cultures grown in M17lac and amounts of lactose and galactose in the medium.
| OD600 | TH1477 | 0.01 ± 0.00 | 1.09 ± 0.09 | 1.97 ± 0.02 | 1.98 ± 0.02 |
| TH1436 | 0.01 ± 0.00 | 0.80 ± 0.01 | 1.90 ± 0.01 | 1.91 ± 0.01 | |
| Lactose (g/L) | TH1477 | 5.12 ± 0.03 | 1.07 ± 0.22*** | 0.01 ± 0.01 | 0.04 ± 0.04 |
| TH1436 | 4.83 ± 0.16 | 2.30 ± 0.14 | 0.02 ± 0.01 | 0.04 ± 0.02 | |
| Galactose (g/L) | TH1477 | 0.02 ± 0.01 | 0.18 ± 0.02* | 0.37 ± 0.04*** | 0.34 ± 0.04*** |
| TH1436 | 0.04 ± 0.02 | 0.15 ± 0.00 | 0.06 ± 0.03 | 0.04 ± 0.02 | |
Values are means ± standard deviations obtained from 3 independent experiments. Asterisks indicate statistically significant differences between strains (ANOVA, Tukey's test).
Figure 1Evolution of pH value during 24 h of growth (acidification curves) of S. thermophilus strains TH1436 and TH1477.
Amino acids substitution in the gal genes cluster.
| TH1436 | V | Y | S | S | D | D | L | E | A | A | L | W | D | S | L | ||||||||||||
| TH1477 | A | K | V | K | Y | S | D | E | V | A | A | L | W | Y | D | L | |||||||||||
| TH982 | A | K | V | K | S | D | D | L | V | I | A | A | F | L | V | D | E | Y | D | S | L | ||||||
| TH985 | A | K | V | K | S | D | D | L | V | A | I | A | A | F | L | V | D | E | Y | D | S | ||||||
| F8CT | A | K | K | Y | S | S | D | L | E | V | A | I | A | L | W | V | D | E | Y | S | L | ||||||
| TH1435 | A | K | V | K | Y | S | S | D | D | L | E | V | A | I | A | F | L | V | D | E | Y | D | S | L | |||
| Level | : | : | : | d | : | : | . | . | : | : | : | : | . | : | : | : | . | : | |||||||||
Figure 2Nucleotide sequences alignment of the galR-galK intergenic region and amino acid sequence alignment of the galR DNA binding site. Alignment of the galR-galK intergenic sequences of the 6 strains. Strain TH1477 (Gal−) was used as reference sequence followed by strain TH1436 (Gal+). The beginning of both galR and galK genes are highlighted in light gray. Promoter sequences were identified according to Vaughan et al. (2001) and Vaillancourt et al. (2002). The −35 and −10 sequences and the ribosome binding site (SD) are in bold and underlined. Transcriptional start sites are defined as +1 and the arrows indicate the inverted repeated sequences of the GalR operator. The conserved nucleotides compared to the sequence of strain TH1477 are represented by dots, while nucleotide substitutions are shown with letter. Variations considered important for the Gal+ phenotype and the cre site are square framed with solid and dashed line respectively. On the top the amino acid sequences alignment of the galR DNA binding site is presented magnified.
Figure 3Representation of gal operon transcript reconstruction. On the top of the figure transcripts coverage on both strands is shown as black graph. Genes are represented by colored boxes while reconstructed transcripts are reported on a separate line represented by red boxes. The predicted UTR regions are shown as pink boxes.
Figure 4Functional categories differentially expressed in the two strains. Categories enriched with genes significantly up-regulated (black bars) and down-regulated (white bars) in TH1436 (Gal+) compared to TH1477 (Gal−). Categories were defined according to the SEED subsystems.
Selection of genes differentially expressed in strains TH1436 (Gal+) and TH1477 (Gal−).
| 223 ± 77 | 43 ± 9 | 8.62 | ***0.000 | Phage shock protein C | gene_0630 | Stress response | |
| 2459 ± 285 | 489 ± 161 | 8.56 | ***0.000 | PTS system, sucrose-specific IIA; IIB; IIC component | gene_1503 | 2.7.1.69 | Carbohydrates |
| 1489 ± 398 | 344 ± 86 | 7.38 | ***0.000 | Superoxide dismutase, DNA binding protein | gene_1775 | 1.15.1.1 | Stress response |
| 1895 ± 231 | 573 ± 393 | 6.50 | ***0.000 | Phage infection protein | gene_1732 | Stress response | |
| 2959 ± 215 | 669 ± 73 | 6.43 | ***0.000 | Galactose-1-phosphate uridylyltransferase | gene_1307 | 2.7.7.10 | Carbohydrates |
| 4759 ± 841 | 1015 ± 430 | 6.33 | ***0.000 | Galactokinase | gene_1308 | 2.7.1.6 | Carbohydrates |
| 518 ± 115 | 176 ± 63 | 5.19 | ***0.000 | Sucrose operon repressor ScrR | gene_1505 | Carbohydrates | |
| 994 ± 138 | 351 ± 173 | 5.17 | ***0.000 | Acetate kinase | gene_1765 | 2.7.2.1 | Carbohydrates |
| 2047 ± 93 | 615 ± 32 | 4.92 | ***0.000 | UDP-glucose 4-epimerase | gene_1306 | 5.1.3.2 | Cell wall and capsule |
| 1195 ± 14 | 484 ± 368 | 4.88 | ***0.000 | 2',3'-cyclic-nucleotide 2'-phosphodiesterase | gene_0286 | 3.1.4.16 | Nucleosides and nucleotides |
| 1132 ± 39 | 394 ± 50 | 4.33 | ***0.001 | PTS system, fructose-specificIIA; IIB; IIC component | gene_0394 | 2.7.1.69 | Carbohydrates |
| 295 ± 42 | 115 ± 32 | 4.22 | ***0.000 | Fumarate reductase, flavoprotein subunit precursor | gene_1676 | 1.3.99.1 | Respiration |
| 181 ± 29 | 88 ± 13 | 3.33 | ***0.000 | Acetoin utilization acuB protein | gene_0331 | 4.2.1.11 | Carbohydrates |
| 31 ± 9 | 162 ± 56 | −4.13 | ***0.000 | Response regulator SaeR | gene_1264 | Cell wall and capsule | |
| 1985 ± 402 | 630 ± 176 | 4.48 | **0.002 | Catabolite control protein A | gene_0619 | Regulation and cell signaling | |
| 883 ± 250 | 297 ± 82 | 4.29 | **0.002 | GTP-sensing transcriptional pleiotropic repressor codY | gene_1392 | Stress response | |
| 873 ± 163 | 386 ± 89 | 3.27 | **0.009 | Phosphate acetyltransferase | gene_1623 | 2.3.1.8 | Carbohydrates |
| 811 ± 18 | 405 ± 76 | 3.18 | **0.003 | Phage lysin, glycosyl hydrolase, family 25 | gene_0686 | Phages, prophages, transposable elements | |
| 549 ± 94 | 378 ± 211 | 2.53 | **0.009 | Glutathione reductase | gene_0395 | 1.8.1.7 | Stress response |
| 210 ± 51 | 151 ± 62 | 2.27 | **0.002 | D-alanyl-D-alanine carboxypeptidase | gene_0094 | 3.4.16.4 | Cell wall and capsule |
| 53 ± 27 | 178 ± 18 | −2.42 | **0.004 | CRISPR-associated RAMP Csm3 | gene_0975 | DNA metabolism | |
| 86 ± 38 | 309 ± 3 | −2.66 | **0.002 | CRISPR-associated protein, Csm5 family | gene_0978 | DNA metabolism | |
| 39 ± 27 | 156 ± 20 | −2.94 | **0.002 | CRISPR repeat RNA endoribonuclease Cas6 | gene_0971 | DNA metabolism | |
| 4352 ± 678 | 1743 ± 641 | 3.42 | *0.012 | Pyruvate formate-lyase | gene_1419 | 2.3.1.54 | Carbohydrates |
| 4234 ± 764 | 1669 ± 965 | 3.28 | *0.024 | Heat shock protein GrpE | gene_0097 | Protein metabolism | |
| 40253 ± 8829 | 16815 ± 10804 | 3.07 | *0.041 | Beta-galactosidase | gene_1302 | 3.2.1.23 | Carbohydrates |
| 4501 ± 325 | 1993 ± 1046 | 2.89 | *0.036 | 1-phosphofructokinase | gene_0392 | 2.7.1.56 | Carbohydrates |
| 22508 ± 3470 | 10029 ± 6199 | 2.86 | *0.050 | Chaperone protein DnaK | gene_0098 | Protein metabolism | |
| 563 ± 134 | 281 ± 117 | 2.75 | *0.034 | Universal stress protein family | gene_1395 | Stress response | |
| 177 ± 19 | 157 ± 73 | 1.99 | *0.017 | Peptidoglycan N-acetylglucosamine deacetylase | gene_1316 | 3.5.1 | Cell wall and capsule |
| 223 ± 52 | 202 ± 87 | 1.80 | *0.027 | PTS system, mannose-specific IIC component | gene_0340 | 2.7.1.69 | Carbohydrates |
| 86 ± 40 | 228 ± 95 | −1.70 | *0.050 | CRISPR-associated protein Cas1 | gene_0969 | DNA metabolism | |
| 160 ± 63 | 423 ± 81 | −1.82 | *0.039 | Urea channel UreI | gene_0146 | Amino acids and derivatives | |
| 103 ± 51 | 258 ± 19 | −1.91 | *0.040 | Urease accessory protein UreD | gene_0154 | Amino acids and derivatives | |
| 61 ± 18 | 167 ± 17 | −2.02 | *0.033 | Urease accessory protein UreE | gene_0151 | Amino acids and derivatives | |
| 63 ± 43 | 172 ± 30 | −2.03 | *0.028 | Urease accessory protein UreG | gene_0153 | Amino acids and derivatives | |
| 45 ± 29 | 131 ± 16 | −2.11 | *0.028 | CRISPR-associated RAMP protein, Csm4 family | gene_0977 | DNA metabolism | |
| 244 ± 158 | 721 ± 100 | −2.19 | *0.033 | CRISPR-associated protein, Csm1 family | gene_0972 | DNA metabolism | |
| 246 ± 62 | 853 ± 377 | −2.81 | *0.024 | Urease accessory protein UreF | gene_0152 | Amino acids and derivatives | |
Average values ± standard deviation of reads per kb per million mapped reads (RPKM) for each strain. Genes are assigned to three groups according to the level of statistical significance, which was reported with asterisks and p-values. The gene expression differences between TH1436 and TH1477 are expressed as fold change; positive values are referred to genes more expressed in TH1436, conversely negative values are those more expressed in TH1477. The description of each gene differentially expressed, the Gene ID and the Enzyme Commission (EC) number are indicated.
Figure 5Schematic representation of main sugars metabolism with indication of differentially expressed genes. PTS transport systems (PTS Scr, PTS system sucrose-specific IIA; IIB; IIC component; PTS Fru, PTS system fructose-specific IIA; IIB; IIC component; PTS Man, PTS system mannose-specific IIA; IIB; IIC component). Lactose transport system (LacS, lactose permease; β-GAL, beta-galactosidase) and metabolism by the Leloir pathway (pink box; GALM, galactose mutarotase; GALK, galactokinase; GALT, galactose-1-phosphate uridylyltransferase; GALE, UDP-glucose 4-epimerase; GALU, UDP glucose pyrophosphorylase). Sugars are internalized (S6PH, sucrose-6-phosphate hydrolase; FK, fructokinase; FRUK, 1-phosphofructokinase; MANA, mannose 6-phosphate isomerase; PGM, phosphoglucomutase) in the Embden-Meyerhof-Parnas pathway (Glycolysis, light blue box; GLUK, glucose kinase; PGI, phosphoglucose isomerase; PFK, phosphofructokinase; PK, pyruvate kinase). Pyruvate is converted to lactate by Homolactic Fermentation (orange box; LDH, lactate dehydrogenase) or metabolized to other products by the Mixed Acid Fermentation (yellow box; PDH, pyruvate dehydrogenase; PFL, pyruvate formate-lyase; FDH, formate dehydrogenase; PTA, phosphate acetyltransferase; ACKA, acetate kinase; ADHE, acetaldehyde-CoA/alcohol dehydrogenase; ADHA, alcohol dehydrogenase; ALS, acetolactate synthase; ALDB, alpha-acetolactate decarboxylase; BUTA, acetoin reductase; BUTB, 2,3-butanediol dehydrogenase; ACUB, acetoin utilization protein). The genes regulated by CcpA are marked with an asterisk. Numbers represent differences in expression determined with RNA-seq.
| TH1436 | E | T | E | M | E | G | G | |||||||||||||
| TH1477 | D | G | Y | D | T | E | M | E | T | I | G | R | V | K | A | G | ||||
| TH982 | D | E | G | Y | D | T | E | E | T | I | S | R | V | K | A | D | ||||
| TH985 | D | E | G | Y | D | T | E | M | E | T | I | S | R | V | K | A | D | |||
| F8CT | D | E | G | Y | D | T | E | M | E | T | I | S | R | V | K | A | D | |||
| TH1435 | D | G | Y | D | M | T | G | R | V | K | A | G | ||||||||
| Level | . | . | : | . | : | : | : | : | : | . | : | : | . | . | ||||||
Amino acids substitutions among strains are highlighted in bold. Total numbers of substitutions (Sub) are shown for each gene of the gal operon. The bottom line indicates deletions (d) and conserved AA between groups of strongly similar properties roughly equivalent to scoring > 0.5 (:) or ≤ 0.5 and > 0 (.) in the Gonnet PAM 250 matrix.